Australia markets close in 3 hours 42 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.45-0.69 (-1.09%)
At close: 04:00PM EDT
62.35 -0.10 (-0.16%)
After hours: 07:44PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close63.14
Bid62.00 x 2900
Ask62.41 x 1300
Day's range62.37 - 63.41
52-week range57.17 - 74.12
Avg. volume6,990,245
Market cap78.332B
Beta (5Y monthly)0.35
PE ratio (TTM)19.10
Earnings dateN/A
Forward dividend & yield2.92 (4.74%)
Ex-dividend date14 Sept 2022
1y target estN/A
  • Motley Fool

    3 Healthcare Stocks With High Profit Margins

    If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.

  • Motley Fool

    2 Reasons This Beaten-Down Stock Could Be About to Rebound

    Gilead Sciences (NASDAQ: GILD) has kept its revenue and earnings growing in the past two years -- if ever so slightly -- largely thanks to Veklury, its COVID-19 therapy. Gilead Sciences' revenue rose by only about 1% year over year to $6.3 billion during the period. Excluding sales of Veklury, which dropped by 46% year over year to $445 million, Gilead Sciences' revenue for the quarter grew by a more impressive and respectable (by industry standards) 7%.

  • Simply Wall St.

    What Kind Of Investors Own Most Of Gilead Sciences, Inc. (NASDAQ:GILD)?

    Every investor in Gilead Sciences, Inc. ( NASDAQ:GILD ) should be aware of the most powerful shareholder groups...